US20130230473A1 - Use of substituted methoxyalkoxyphenylalkyl derivatives as preservative, preserving method, compounds and composition - Google Patents
Use of substituted methoxyalkoxyphenylalkyl derivatives as preservative, preserving method, compounds and composition Download PDFInfo
- Publication number
- US20130230473A1 US20130230473A1 US13/824,172 US201113824172A US2013230473A1 US 20130230473 A1 US20130230473 A1 US 20130230473A1 US 201113824172 A US201113824172 A US 201113824172A US 2013230473 A1 US2013230473 A1 US 2013230473A1
- Authority
- US
- United States
- Prior art keywords
- composition
- formula
- weight
- compound
- saturated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- ZEMQALDXESBLJA-UHFFFAOYSA-N CC(=O)CCC1=CC=C(CO)C(CO)=C1.CC(=O)CCC1=CC=C(CO)C(O)=C1.CC(O)CCC1=CC=C(CO)C(CO)=C1.CC(O)CCC1=CC=C(CO)C(O)=C1 Chemical compound CC(=O)CCC1=CC=C(CO)C(CO)=C1.CC(=O)CCC1=CC=C(CO)C(O)=C1.CC(O)CCC1=CC=C(CO)C(CO)=C1.CC(O)CCC1=CC=C(CO)C(O)=C1 ZEMQALDXESBLJA-UHFFFAOYSA-N 0.000 description 4
- 0 [2*]C(CC1=CC=C(CO)C([1*]O)=C1)C([3*])C Chemical compound [2*]C(CC1=CC=C(CO)C([1*]O)=C1)C([3*])C 0.000 description 4
- CCBOJKAZUOZRQC-UHFFFAOYSA-N CC(C)C(C)CC1=CC=C(CO)C(O)=C1 Chemical compound CC(C)C(C)CC1=CC=C(CO)C(O)=C1 CCBOJKAZUOZRQC-UHFFFAOYSA-N 0.000 description 2
- HABFMTQRTDHSJT-UHFFFAOYSA-N CC(=O)CCC1=CC=C(CO)C(O)=C1 Chemical compound CC(=O)CCC1=CC=C(CO)C(O)=C1 HABFMTQRTDHSJT-UHFFFAOYSA-N 0.000 description 1
- PVFXJRIXTNKSIF-UHFFFAOYSA-N CC(CCc(cc1O)ccc1OC)=O Chemical compound CC(CCc(cc1O)ccc1OC)=O PVFXJRIXTNKSIF-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/002—Aftershave preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
Definitions
- the present invention relates to the use of substituted derivatives of methoxyalkoxyphenylalkyl type, in particular as a preservative in cosmetic or dermatological compositions; the invention also relates to novel compounds that can be used in cosmetology or in dermatology, and also to the compositions comprising these compounds.
- One object of the present invention is to propose novel preserving agents which in particular have a broad antimicrobial spectrum, at least as broad, or even broader, than that of the already existing compounds, and which do not have the drawbacks of the prior art, in particular which have specific physicochemical properties making it possible to protect cosmetic formulas against microbial contamination while at the same time being well tolerated.
- a subject of the invention is therefore the use as a preserving agent, in particular in a cosmetic or dermatological composition, of at least one compound of formula (I), alone or as a mixture, as defined hereinafter.
- preserving agent is intended to mean a substance which is commonly added to a composition in order to preserve said composition with respect to a contaminating agent.
- the compounds of formula (I) according to the invention are used as an antimicrobial and/or antibacterial and/or antifungal agent.
- Another subject of the invention is a method for preserving a cosmetic or dermatological composition, characterized in that it consists in incorporating into said composition at least one compound of formula (I) as defined hereinafter.
- X represents ⁇ O
- C being the carbon atom to which X is attached.
- R3 is a C1-C6, saturated or unsaturated, linear hydrocarbon-based radical, optionally substituted with a hydroxyl group (OH).
- R3 is saturated.
- R2 represents a hydrogen atom.
- the compounds of formula (I) are such that:
- R3 represents a C1-C12, saturated or unsaturated, linear hydrocarbon-based radical, optionally substituted with a hydroxyl group (OH); preferentially R3 represents a C1-C12, in particular C1-C10, or even C1-C6, even better still C1-C4, saturated linear hydrocarbon-based (alkyl) radical;
- R3 represents a C1-C6, saturated or unsaturated, linear hydrocarbon-based radical, optionally substituted with a hydroxyl group (OH); preferentially R3 represents a C1-C6, in particular C1-C5, or even C1-C4, saturated linear hydrocarbon-based (alkyl) radical.
- the composition does not comprise any preserving agents other than those of formula (I).
- the composition preferably does not contain parabens.
- R′3 is a C2-C6, in particular C3-C4, saturated or unsaturated, linear hydrocarbon-based radical.
- R′3 is saturated (alkyl).
- R′2 represents a hydrogen atom.
- compositions comprising at least one compound of formula (I′) also form a subject of the present invention.
- the compounds of formula (I), alone or as a mixture, can be used in a proportion of from 0.01 to 10% by weight, in particular 0.1 to 5% by weight, relative to the weight of the composition, in particular cosmetic or dermatological composition.
- the cosmetic or dermatological compositions comprise, moreover, a cosmetically or dermatologically acceptable medium, i.e. a medium which is compatible with keratin materials such as facial or body skin, the lips, the hair, the eyelashes, the eyebrows and the nails.
- a cosmetically or dermatologically acceptable medium i.e. a medium which is compatible with keratin materials such as facial or body skin, the lips, the hair, the eyelashes, the eyebrows and the nails.
- compositions according to the invention may be in any of the galenical forms conventionally used, in particular for topical application, and in particular in the form of aqueous or aqueous-alcoholic solutions, of oil-in-water (O/W) or water-in-oil (W/O) or multiple (triple: W/O/W or O/W/O) emulsions, of aqueous gels, or of dispersions of a fatty phase in an aqueous phase by means of spherules, it being possible for these spherules to be polymeric nanoparticles such as nanospheres and nanocapsules, or lipid vesicles of ionic and/or nonionic type (liposomes, niosomes, oleosomes), of nanoemulsions, or of thin films.
- These compositions are prepared according to the usual methods.
- compositions according to the invention may be more or less fluid and may have the appearance of a white or coloured cream, an ointment, a milk, a lotion, a serum, a paste or a foam. They can optionally be applied to the skin in the form of an aerosol. They can also be in solid form, for example in the form of a stick.
- the cosmetic or dermatological composition according to the invention may in particular be in the form:
- physiologically acceptable medium in which the compounds can be used, and also its constituents, their amount, the galenical form of the composition and the method for preparing said composition can be chosen by those skilled in the art on the basis of their general knowledge according to the type of composition desired.
- composition may comprise any fatty substance normally used in the field of application envisaged.
- the composition may also comprise an aqueous medium which comprises water, an aqueous-alcoholic medium containing at least one C2-C6 alcohol such as ethanol or isopropanol, or an organic medium comprising customary organic solvents, such as C2-C6 alcohols, in particular ethanol and isopropanol, glycols such as propylene glycol, or ketones.
- an aqueous medium which comprises water, an aqueous-alcoholic medium containing at least one C2-C6 alcohol such as ethanol or isopropanol, or an organic medium comprising customary organic solvents, such as C2-C6 alcohols, in particular ethanol and isopropanol, glycols such as propylene glycol, or ketones.
- composition according to the invention may also comprise the adjuvants customary in the cosmetic and dermatological fields, such as thickeners, emulsifiers, surfactants, gelling agents, active cosmetic agents, fragrances, fillers, colorants, moisturizers, vitamins or polymers.
- adjuvants customary in the cosmetic and dermatological fields such as thickeners, emulsifiers, surfactants, gelling agents, active cosmetic agents, fragrances, fillers, colorants, moisturizers, vitamins or polymers.
- the amounts of these various adjuvants are those conventionally used in the fields under consideration, for example from 0.001 to 20% of the total weight of the composition.
- These adjuvants, and also their concentrations, should be such that they are not detrimental to the advantageous properties of the compounds according to the invention.
- compositions according to the invention when they comprise at least one aqueous phase (aqueous solutions, emulsions for example), is preferably between 4 and 9, preferably between 4 and 7, and advantageously between 5 and 6.
- the antimicrobial efficacy of a compound of formula (I) was evaluated by the Challenge Test or artificial contamination method.
- the challenge test method consists of an artificial contamination of the sample with microbial strains from collection (bacteria, yeasts and moulds) and of an evaluation of the number of revivable microorganisms seven days after inoculation.
- sorbitan tristearate (Span 65 V ® from Croda) 0.9% polyethylene glycol stearate (40 EO) (Myrj 52 P ® from 2.0% Croda) mixture of glyceryl mono-distearate (36/64)/potassium 3.0% stearate fatty acids of vegetable origin (stearic acid/palmitic 1.0% acid/myristic acid 53/44/3) cetyl alcohol 3.8% myristyl myristate 2.0% cyclopentasiloxane 5.0% fillers 0.8% glycerol 3.0% hydrogenated isoparaffin 7.2% white petroleum jelly 4% water qs 100%
- the gram ⁇ bacterial strains Escherichia coli and Pseudomonas aeruginosa
- the gram+bacterial strain Enterococcus faecalis
- the yeast strain Candida albicans
- the mould strain Aspergillus niger
- the amount of microorganisms present in the product corresponds, after homogenization, to a concentration of 10 6 microorganisms per gram of product, i.e. the inoculation at 1% of an inoculum containing 10 8 microorganisms per ml. After 7 or 14 days of contact time between the microorganisms and the product at 22° C. ⁇ 2° C. and in the dark, ten-fold dilutions are carried out and the number of revivable microorganisms remaining in the product is counted.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
- The present invention relates to the use of substituted derivatives of methoxyalkoxyphenylalkyl type, in particular as a preservative in cosmetic or dermatological compositions; the invention also relates to novel compounds that can be used in cosmetology or in dermatology, and also to the compositions comprising these compounds.
- It is common practice to introduce chemical preservatives into cosmetic or dermatological compositions, these preservatives being intended to combat the growth of microorganisms in these compositions, which would quickly make them unsuitable for use. It is in particular necessary to protect compositions against microorganisms capable of growing inside the composition, for example during production thereof, and also against those which the user might introduce therein while handling it, in particular when taking up the products in jars with the fingers. Chemical preservatives commonly used are in particular parabens, organic acids or formol-releasing compounds. However, these preservatives have the drawback of causing irritation, in particular on sensitive skin, when they are present at relatively high levels. Moreover, in the interests of the environment, consumers are increasingly searching for environmentally friendly, in particular nonecotoxic, preserving agents. In addition, the effectiveness of the preservatives conventionally used is variable and their formulation can pose problems, in particular of incompatibility, or even of destabilization, of formulas, in particular of emulsions.
- One object of the present invention is to propose novel preserving agents which in particular have a broad antimicrobial spectrum, at least as broad, or even broader, than that of the already existing compounds, and which do not have the drawbacks of the prior art, in particular which have specific physicochemical properties making it possible to protect cosmetic formulas against microbial contamination while at the same time being well tolerated.
- A subject of the invention is therefore the use as a preserving agent, in particular in a cosmetic or dermatological composition, of at least one compound of formula (I), alone or as a mixture, as defined hereinafter.
- The term “preserving agent” is intended to mean a substance which is commonly added to a composition in order to preserve said composition with respect to a contaminating agent. Advantageously, the compounds of formula (I) according to the invention are used as an antimicrobial and/or antibacterial and/or antifungal agent.
- Another subject of the invention is a method for preserving a cosmetic or dermatological composition, characterized in that it consists in incorporating into said composition at least one compound of formula (I) as defined hereinafter.
- The compounds according to the invention thus correspond to formula (I):
- in which:
- X represents ═O or —OH;
- R1 represents a hydrogen atom or a methyl;
- R2 represents a hydrogen atom, a methyl or an ethyl;
- R3 represents a C1-C12, saturated or unsaturated, linear hydrocarbon-based radical, optionally substituted with a hydroxyl group (OH);
with the exclusion of the compound of formula (I) in which X represents ═O, R1=methyl, R2=H and R3=—(CH2)6—CH3. - The term “X represents ═O” is intended to mean that C—X represents C═O, C being the carbon atom to which X is attached.
- Preferably, R3 is a C1-C6, saturated or unsaturated, linear hydrocarbon-based radical, optionally substituted with a hydroxyl group (OH).
- Preferentially, R3 is saturated.
- Preferably, R2 represents a hydrogen atom.
- Preferably, the compounds of formula (I) are such that:
- (i) when R1=H, R3 represents a C1-C12, saturated or unsaturated, linear hydrocarbon-based radical, optionally substituted with a hydroxyl group (OH); preferentially R3 represents a C1-C12, in particular C1-C10, or even C1-C6, even better still C1-C4, saturated linear hydrocarbon-based (alkyl) radical;
- (ii) when R1=CH3, R3 represents a C1-C6, saturated or unsaturated, linear hydrocarbon-based radical, optionally substituted with a hydroxyl group (OH); preferentially R3 represents a C1-C6, in particular C1-C5, or even C1-C4, saturated linear hydrocarbon-based (alkyl) radical.
- Mention may in particular be made of the following compounds of formula (I):
- A mixture of compounds of formula (I) can of course be used.
- Preferably, the composition does not comprise any preserving agents other than those of formula (I). In particular, the composition preferably does not contain parabens.
- Certain compounds of formula (I) are novel and also form a subject of the present invention; they are the compounds of formula (I′) hereinafter:
- in which:
- R′2 represents a hydrogen atom, a methyl or an ethyl;
- X′ represents ═O or —OH,
- when X′ represents =0, R′3 represents a C3-C12, saturated or unsaturated, linear hydrocarbon-based radical, and
- when X′ represents OH, R′3 represents a C2-C12, saturated or unsaturated, linear hydrocarbon-based radical.
- Preferably, R′3 is a C2-C6, in particular C3-C4, saturated or unsaturated, linear hydrocarbon-based radical. Preferentially, R′3 is saturated (alkyl).
- Preferably, R′2 represents a hydrogen atom.
- The cosmetic or dermatological compositions comprising at least one compound of formula (I′) also form a subject of the present invention.
- The compounds of formula (I) can be readily prepared by those skilled in the art on the basis of their general knowledge. They can thus be prepared from commercially available isovanillin (CAS 6221-59-0) when R1=H or from commercially available veratraldehyde (CAS 120-14-9) when R1=methyl, in the following way:
- The compounds of formula (I), alone or as a mixture, can be used in a proportion of from 0.01 to 10% by weight, in particular 0.1 to 5% by weight, relative to the weight of the composition, in particular cosmetic or dermatological composition.
- The cosmetic or dermatological compositions comprise, moreover, a cosmetically or dermatologically acceptable medium, i.e. a medium which is compatible with keratin materials such as facial or body skin, the lips, the hair, the eyelashes, the eyebrows and the nails.
- The compositions according to the invention may be in any of the galenical forms conventionally used, in particular for topical application, and in particular in the form of aqueous or aqueous-alcoholic solutions, of oil-in-water (O/W) or water-in-oil (W/O) or multiple (triple: W/O/W or O/W/O) emulsions, of aqueous gels, or of dispersions of a fatty phase in an aqueous phase by means of spherules, it being possible for these spherules to be polymeric nanoparticles such as nanospheres and nanocapsules, or lipid vesicles of ionic and/or nonionic type (liposomes, niosomes, oleosomes), of nanoemulsions, or of thin films. These compositions are prepared according to the usual methods.
- The compositions according to the invention may be more or less fluid and may have the appearance of a white or coloured cream, an ointment, a milk, a lotion, a serum, a paste or a foam. They can optionally be applied to the skin in the form of an aerosol. They can also be in solid form, for example in the form of a stick.
- The cosmetic or dermatological composition according to the invention may in particular be in the form:
- of a care or makeup product, in particular for facial or body skin, the lips, the eyelashes, the nails, the hair;
- of an aftershave gel or lotion;
- of a hair-removing cream;
- of a suntan or self-tanning composition;
- of a body or hair hygiene composition, such as a shower gel or a shampoo;
- of a solid cosmetic composition such as a cleansing bar or soap;
- of an aerosol composition also comprising a pressurised propellant;
- of a hair composition, in particular a hair setting lotion, a styling cream or gel, a dyeing composition, a hair restructuring lotion, a permanent-wave composition, an anti-hair loss lotion or gel;
- of a composition for oro-dental use.
- The physiologically acceptable medium in which the compounds can be used, and also its constituents, their amount, the galenical form of the composition and the method for preparing said composition can be chosen by those skilled in the art on the basis of their general knowledge according to the type of composition desired.
- In particular, the composition may comprise any fatty substance normally used in the field of application envisaged.
- The composition may also comprise an aqueous medium which comprises water, an aqueous-alcoholic medium containing at least one C2-C6 alcohol such as ethanol or isopropanol, or an organic medium comprising customary organic solvents, such as C2-C6 alcohols, in particular ethanol and isopropanol, glycols such as propylene glycol, or ketones.
- The composition according to the invention may also comprise the adjuvants customary in the cosmetic and dermatological fields, such as thickeners, emulsifiers, surfactants, gelling agents, active cosmetic agents, fragrances, fillers, colorants, moisturizers, vitamins or polymers. The amounts of these various adjuvants are those conventionally used in the fields under consideration, for example from 0.001 to 20% of the total weight of the composition. These adjuvants, and also their concentrations, should be such that they are not detrimental to the advantageous properties of the compounds according to the invention.
- The pH of the compositions according to the invention, when they comprise at least one aqueous phase (aqueous solutions, emulsions for example), is preferably between 4 and 9, preferably between 4 and 7, and advantageously between 5 and 6.
- The invention is illustrated in greater detail in the following exemplary embodiments.
- The antimicrobial efficacy of a compound of formula (I) was evaluated by the Challenge Test or artificial contamination method.
-
- The challenge test method consists of an artificial contamination of the sample with microbial strains from collection (bacteria, yeasts and moulds) and of an evaluation of the number of revivable microorganisms seven days after inoculation.
- In order to demonstrate the effect of compounds of formula (I), the antimicrobial activity of a cosmetic formula containing 2% of compound according to the invention was compared with the same formula alone (control), after inoculation of approximately 106 CFU (colony-forming units)/gram of cosmetic formula.
-
-
sorbitan tristearate (Span 65 V ® from Croda) 0.9% polyethylene glycol stearate (40 EO) (Myrj 52 P ® from 2.0% Croda) mixture of glyceryl mono-distearate (36/64)/potassium 3.0% stearate fatty acids of vegetable origin (stearic acid/palmitic 1.0% acid/myristic acid 53/44/3) cetyl alcohol 3.8% myristyl myristate 2.0% cyclopentasiloxane 5.0% fillers 0.8% glycerol 3.0% hydrogenated isoparaffin 7.2% white petroleum jelly 4% water qs 100% - 5 pure cultures of microorganisms are used.
-
MICROORGANISMS Subculturing medium T° ATCC Escherichia coli (Ec) Trypto-casein soy 35° C. 8739 Enterococcus faecalis (Ef) Trypto-casein soy 35° C. 33186 Pseudomonas aeruginosa (Pa) Trypto-casein soy 35° C. 19429 Candida albicans (Ca) Sabouraud 35° C. 10231 Aspergillus niger (An) Malt 35° C. 6275 ATCC = American Type Culture Collection - The gram−bacterial strains (Escherichia coli and Pseudomonas aeruginosa), the gram+bacterial strain (Enterococcus faecalis), the yeast strain (Candida albicans), and the mould strain (Aspergillus niger) are inoculated into subculturing medium, respectively the day before inoculation for the bacteria and the yeast, and 5 days before inoculation for the mould.
- On the day of inoculation:
- a suspension in tryptone salt diluent is prepared respectively for the bacteria and the yeast in such a way as to obtain, on a spectrophotometer, a suspension having an optical density between 35% and 45% of transmitted light at 544 nm;
- for the mould, the spores are taken by washing the agar with 6 to 7 ml of harvesting solution and the suspension is recovered in a sterile flask or tube.
- After having homogenized the microbial suspension, 0.2 ml of inoculum (the suspensions are used pure: between 1×108 and 3×108 CFU per ml) are placed in each pill bottle and the microbial suspension is completely homogenized in the 20 g of product (=cosmetic formula) using a spatula.
- The amount of microorganisms present in the product corresponds, after homogenization, to a concentration of 106 microorganisms per gram of product, i.e. the inoculation at 1% of an inoculum containing 108 microorganisms per ml. After 7 or 14 days of contact time between the microorganisms and the product at 22° C.±2° C. and in the dark, ten-fold dilutions are carried out and the number of revivable microorganisms remaining in the product is counted.
-
-
Number of CFU/gram of product at T = 7 days Amount E. coli P. aeruginosa E. faecalis C. albicans A. niger Compound 2% <200 <200 7.3 · 105 <200 1.4 · 106 <200 CFU: sensitivity threshold of the method -
Number of CFU/gram of product at T = 14 days Amount E. coli P. aeruginosa E. faecalis C. albicans A. niger Compound 2% — — 3.3 · 108 — 3.6 · 105 <200 CFU: sensitivity threshold of the method
Claims (20)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/824,172 US9381143B2 (en) | 2010-10-08 | 2011-10-06 | Use of substituted methoxyalkoxyphenylalkyl derivatives as preservative, preserving method, compounds and composition |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1058182 | 2010-10-08 | ||
FR1058182A FR2965730B1 (en) | 2010-10-08 | 2010-10-08 | USE OF SUBSTITUTED METHOXYALCOXYPHENYL-ALKYL DERIVATIVES AS A PRESERVATIVE, METHOD OF PRESERVATION, COMPOUNDS AND COMPOSITION |
EP1058182 | 2010-10-08 | ||
US39208210P | 2010-10-12 | 2010-10-12 | |
PCT/EP2011/067450 WO2012045809A1 (en) | 2010-10-08 | 2011-10-06 | Use of substituted methoxyalkoxyphenylalkyl derivatives as preservative, preserving method, compounds and composition |
US13/824,172 US9381143B2 (en) | 2010-10-08 | 2011-10-06 | Use of substituted methoxyalkoxyphenylalkyl derivatives as preservative, preserving method, compounds and composition |
Publications (2)
Publication Number | Publication Date |
---|---|
US20130230473A1 true US20130230473A1 (en) | 2013-09-05 |
US9381143B2 US9381143B2 (en) | 2016-07-05 |
Family
ID=43858102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/824,172 Active 2032-06-05 US9381143B2 (en) | 2010-10-08 | 2011-10-06 | Use of substituted methoxyalkoxyphenylalkyl derivatives as preservative, preserving method, compounds and composition |
Country Status (8)
Country | Link |
---|---|
US (1) | US9381143B2 (en) |
EP (1) | EP2624808B1 (en) |
JP (1) | JP2014503468A (en) |
CN (1) | CN103124550B (en) |
BR (1) | BR112013002951B1 (en) |
ES (1) | ES2627852T3 (en) |
FR (1) | FR2965730B1 (en) |
WO (1) | WO2012045809A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3022773B1 (en) | 2014-06-30 | 2016-07-29 | Oreal | USE OF 4- (3-ETHOXY-4-HYDROXYPHENYL) ALKYLCETONE AS A SKIN SOOTHING AGENT |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100278991A1 (en) * | 2009-04-29 | 2010-11-04 | John Christian Haught | Methods for Improving Taste and Oral Care Compositions With Improved Taste |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2700041A (en) * | 1951-08-21 | 1955-01-18 | Abbott Lab | 6-benzyloxy-7-methoxy-1-methyl-3, 4-dihydroisoquinoline and its process of preparation |
US4897406A (en) | 1987-11-13 | 1990-01-30 | Nisshin Flour Milling Co., Ltd. | Rhodanine derivatives and pharmaceutical compositions |
KR20020043073A (en) * | 2000-12-01 | 2002-06-08 | 김대실 | A toilet soap containing ginger ingredient |
KR100367970B1 (en) | 2000-12-01 | 2003-01-24 | 애경화학 주식회사 | Method for preparing of alkoxy methyl melamine resin etherficated by the alcohol groups |
US20050171211A1 (en) * | 2002-05-27 | 2005-08-04 | Hisatoyo Kato | Gingerol analogues and use thereof |
CN1462797A (en) * | 2002-05-30 | 2003-12-24 | 金大宝 | Soap compsn, contg. ginger content, and its mfg. process |
EP1560556A4 (en) * | 2002-08-12 | 2011-07-06 | Lonza Ag | Antimicrobial compositions |
US20080253976A1 (en) * | 2007-04-16 | 2008-10-16 | Douglas Craig Scott | Personal Care Compositions Comprising An Antimicrobial Blend of Essential Oils or Constituents Thereof |
-
2010
- 2010-10-08 FR FR1058182A patent/FR2965730B1/en not_active Expired - Fee Related
-
2011
- 2011-10-06 BR BR112013002951-0A patent/BR112013002951B1/en active IP Right Grant
- 2011-10-06 ES ES11770081.5T patent/ES2627852T3/en active Active
- 2011-10-06 WO PCT/EP2011/067450 patent/WO2012045809A1/en active Application Filing
- 2011-10-06 CN CN201180048775.0A patent/CN103124550B/en active Active
- 2011-10-06 US US13/824,172 patent/US9381143B2/en active Active
- 2011-10-06 JP JP2013532193A patent/JP2014503468A/en active Pending
- 2011-10-06 EP EP11770081.5A patent/EP2624808B1/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100278991A1 (en) * | 2009-04-29 | 2010-11-04 | John Christian Haught | Methods for Improving Taste and Oral Care Compositions With Improved Taste |
Non-Patent Citations (2)
Title |
---|
Junkichi Murai, Synthesis of m-hydroxyphenylethyl methyl ketone and 3-hydroxy-4-methoxyphenylethyl ketone (isozingerone), Science Reports of the Tohoku Imerial, Volumn 14, Series 1, pp 149-54, 1925 * |
Takagaki et al., Topical Application of Ethyl Ether to Recurrent Herpes Simplex, April 1981, The Journal of Dermatology, Volume 8, Issue 2, pp. 109-111, Abstract * |
Also Published As
Publication number | Publication date |
---|---|
US9381143B2 (en) | 2016-07-05 |
JP2014503468A (en) | 2014-02-13 |
BR112013002951A2 (en) | 2020-08-25 |
CN103124550A (en) | 2013-05-29 |
FR2965730B1 (en) | 2013-03-29 |
WO2012045809A1 (en) | 2012-04-12 |
EP2624808B1 (en) | 2017-03-22 |
CN103124550B (en) | 2017-01-18 |
BR112013002951B1 (en) | 2021-02-23 |
ES2627852T3 (en) | 2017-07-31 |
FR2965730A1 (en) | 2012-04-13 |
EP2624808A1 (en) | 2013-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11306051B2 (en) | Use of vanillin derivatives as a preservative, preservation method, compounds, and composition | |
US20120269739A1 (en) | Composition, use, and preservation method | |
CN111031794B (en) | Antimicrobial mixture containing 4- (3-ethoxy-4-hydroxyphenyl) butan-2-one and organic acid compound, and cosmetic composition containing the same | |
US11752079B2 (en) | Antimicrobial mixture containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one and a diol, and cosmetic composition containing same | |
EP3644738B1 (en) | Antimicrobial mixture containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one and an aromatic alcohol, and cosmetic composition containing same | |
US9381143B2 (en) | Use of substituted methoxyalkoxyphenylalkyl derivatives as preservative, preserving method, compounds and composition | |
US11207251B2 (en) | Antimicrobial mixture containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one and chlorphenesin, and cosmetic composition containing same | |
US9427604B2 (en) | Use of benzyloxy-ethylamine derivatives as a preservative, preservation method, and compositions | |
FR3068205B1 (en) | ANTIMICROBIAL MIXTURE CONTAINING 4- (3-ETHOXY-4-HYDROXYPHENYL) BUTAN-2-ONE AND PHENYL ETHYL ALCOHOL, AND COSMETIC COMPOSITION CONTAINING SAME | |
FR3070107A1 (en) | ANTIMICROBIAL MIXTURE CONTAINING 4- (3-ETHOXY-4-HYDROXYPHENYL) BUTAN-2-ONE AND PHENOXYALCOOL, AND COSMETIC COMPOSITION CONTAINING SAME | |
FR3073396A1 (en) | ANTIMICROBIAL MIXTURE CONTAINING 4- (3-ETHOXY-4-HYDROXYPHENYL) BUTAN-2-ONE AND A HYDROXAMIC ACID, AND COSMETIC COMPOSITION CONTAINING THE SAME |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: L'OREAL, FRANCE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DALKO, MARIA;GILBERT, LAURENT;SIGNING DATES FROM 20130404 TO 20130409;REEL/FRAME:030786/0061 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 4 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 8 |